What is the TAME Trial?
The Targeting Aging with Metformin (TAME) Trial is a series of nationwide, six-year clinical trials at 14 leading research institutions across the country that will engage over 3,000 individuals between the ages of 65-79.
Led by AFAR Scientific Director Nir Barzilai, MD, these trials will test whether those taking metformin experience delayed development or progression of age-related chronic diseases—such as heart disease, cancer, and dementia.
Trying to prove/demonstrate that pharmaceutical intervention in the guise of Metformin is the cure for aging and age-related degeneration? Is it soooooo difficult for people to cut carbs?